646 related articles for article (PubMed ID: 11843690)
1. Refractory status epilepticus: frequency, risk factors, and impact on outcome.
Mayer SA; Claassen J; Lokin J; Mendelsohn F; Dennis LJ; Fitzsimmons BF
Arch Neurol; 2002 Feb; 59(2):205-10. PubMed ID: 11843690
[TBL] [Abstract][Full Text] [Related]
2. A one-year prospective study of refractory status epilepticus in Modena, Italy.
Giovannini G; Monti G; Polisi MM; Mirandola L; Marudi A; Pinelli G; Valzania F; Girardis M; Nichelli PF; Meletti S
Epilepsy Behav; 2015 Aug; 49():141-5. PubMed ID: 26074182
[TBL] [Abstract][Full Text] [Related]
3. Identification of Risk Factors for Refractory Status Epilepticus.
Tatro HA; Hamilton LA; Peters C; Rowe AS
Ann Pharmacother; 2020 Jan; 54(1):14-21. PubMed ID: 31347376
[No Abstract] [Full Text] [Related]
4. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit.
Holtkamp M; Othman J; Buchheim K; Meierkord H
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):534-9. PubMed ID: 15774441
[TBL] [Abstract][Full Text] [Related]
5. Aborted and refractory status epilepticus in children: a comparative analysis.
Lambrechtsen FA; Buchhalter JR
Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
[TBL] [Abstract][Full Text] [Related]
6. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.
Madžar D; Reindl C; Giede-Jeppe A; Bobinger T; Sprügel MI; Knappe RU; Hamer HM; Huttner HB
Crit Care; 2018 Nov; 22(1):317. PubMed ID: 30463604
[TBL] [Abstract][Full Text] [Related]
7. Refractory status epilepticus: a prospective observational study.
Novy J; Logroscino G; Rossetti AO
Epilepsia; 2010 Feb; 51(2):251-6. PubMed ID: 19817823
[TBL] [Abstract][Full Text] [Related]
8. Early Clinical Variables Associated With Refractory Convulsive Status Epilepticus in Children.
Peariso K; Arya R; Glauser T; Abend NS; Barcia Aguilar C; Amengual-Gual M; Anderson A; Appavu BL; Brenton JN; Carpenter J; Chapman KE; Clark J; Gaillard WD; Gaínza-Lein M; Goldstein J; Goodkin H; Grinspan Z; Guerriero RM; Horn PS; Huh L; Kahoud R; Kelley SA; Kossoff EH; Kapur K; Lai YC; Marquis BO; McDonough T; Mikati MA; Morgan L; Novotny E; Ostendorf AP; Payne ET; Piantino J; Riviello J; Sands T; Stafstrom CE; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
Neurology; 2023 Aug; 101(5):e546-e557. PubMed ID: 37295955
[TBL] [Abstract][Full Text] [Related]
9. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment.
Mitchell WG
Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
11. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
Dubey D; Bhoi SK; Kalita J; Misra UK
Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
[TBL] [Abstract][Full Text] [Related]
12. Uric acid is a useful marker to differentiate between responsive and refractory status epilepticus.
Choi JY; Hong JM; Kim TJ; Kim BG; Huh K
Clin Neurol Neurosurg; 2019 Sep; 184():105454. PubMed ID: 31376771
[TBL] [Abstract][Full Text] [Related]
13. Status epilepticus: Refractory and super-refractory.
Dubey D; Kalita J; Misra UK
Neurol India; 2017; 65(Supplement):S12-S17. PubMed ID: 28281491
[TBL] [Abstract][Full Text] [Related]
14. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
Rossetti AO; Logroscino G; Bromfield EB
Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
[TBL] [Abstract][Full Text] [Related]
15. Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus.
Rao SK; Mahulikar A; Ibrahim M; Shah A; Seraji-Bozorgzad N; Mohamed W
Epileptic Disord; 2018 Aug; 20(4):265-269. PubMed ID: 30113012
[TBL] [Abstract][Full Text] [Related]
16. Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
Reddy DS
J Pharmacol Exp Ther; 2024 Jan; 388(2):273-300. PubMed ID: 37977814
[TBL] [Abstract][Full Text] [Related]
17. Predictors of outcome in refractory status epilepticus.
Hocker SE; Britton JW; Mandrekar JN; Wijdicks EF; Rabinstein AA
JAMA Neurol; 2013 Jan; 70(1):72-7. PubMed ID: 23318514
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting mortality of refractory status epilepticus.
Tatlidil I; Ture HS; Akhan G
Acta Neurol Scand; 2020 Feb; 141(2):123-131. PubMed ID: 31550052
[TBL] [Abstract][Full Text] [Related]
19. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.
Kantanen AM; Sairanen J; Kälviäinen R
Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204
[TBL] [Abstract][Full Text] [Related]
20. Very high dose phenobarbital for refractory status epilepticus.
Tiamkao S; Mayurasakorn N; Suko P; Jitpimolmard S; Arunpongpaisal S; Phuttharak W; Auevitchayapat N; Vannaprasaht S; Tiamkao S; Phunikhom K; Chaiyakum A; Saengsuwan J
J Med Assoc Thai; 2007 Dec; 90(12):2597-600. PubMed ID: 18386708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
